🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Biomind Labs Inc. (BMNDF)
OTCMKTS · Delayed Price · Currency is USD
0.2153
0.00 (0.00%)
At close: Nov 12, 2026

Biomind Labs Statistics

Total Valuation

Biomind Labs has a market cap or net worth of 16.70 million. The enterprise value is 17.53 million.

Market Cap16.70M
Enterprise Value 17.53M

Important Dates

The next estimated earnings date is Monday, November 23, 2026.

Earnings Date Nov 23, 2026
Ex-Dividend Date n/a

Share Statistics

Biomind Labs has 77.57 million shares outstanding.

Current Share Class 77.57M
Shares Outstanding 77.57M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 36.31%
Owned by Institutions (%) n/a
Float 49.41M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio 0.03
Quick Ratio 0.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -21.22

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -1,630.07%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 75.49%
Weighted Average Cost of Capital (WACC) 44.73%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 5
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 7.75
52-Week Price Change n/a
50-Day Moving Average 0.21
200-Day Moving Average n/a
Relative Strength Index (RSI) 46.19
Average Volume (20 Days) 11,855

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.54M
Pretax Income -1.63M
Net Income -1.63M
EBITDA -1.54M
EBIT -1.54M
Earnings Per Share (EPS) -0.02
Full Income Statement

Balance Sheet

The company has 60,568 in cash and 925,338 in debt, with a net cash position of -864,770 or -0.01 per share.

Cash & Cash Equivalents 60,568
Total Debt 925,338
Net Cash -864,770
Net Cash Per Share -0.01
Equity (Book Value) -2.04M
Book Value Per Share -0.03
Working Capital -2.04M
Full Balance Sheet

Cash Flow

Operating Cash Flow -238,255
Capital Expenditures n/a
Depreciation & Amortization 1,673
Net Borrowing 247,078
Free Cash Flow -238,255
FCF Per Share -0.00
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Biomind Labs does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -9.78%
FCF Yield -1.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1